Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;25(6):1196-1199.
doi: 10.3201/eid2506.180240.

Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017

Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017

Zheng Xu et al. Emerg Infect Dis. 2019 Jun.

Abstract

During the 2008-2012 pertussis epidemic in Australia, pertactin (Prn)-negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013-2017 epidemic and documented continued expansion of Prn-negative ptxP3 B. pertussis strains. We also detected a filamentous hemagglutinin-negative and Prn-negative B. pertussis isolate.

Keywords: Australia; Bordetella pertussis; Fha-negative; Pertactin; Prn-negative; acellular vaccine; bacteria; filamentous haemagglutinin; fim2; pertussis; ptxP3.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pertussis trends and temporal changes of allele frequencies of vaccine antigens genes, Australia. A) Pertussis notifications in Australia, 1991–2017. Source: National Notifiable Diseases Surveillance System (http://www9.health.gov.au/cda/source/cda-index.cfm). Incidence is number of cases per 100,000 population. Reporting system was established in 1991. ACV was first introduced in Australia in 1997, and WCV was replaced with ACV in 1999. A large pertussis epidemic occurred during 2008–2012, and another epidemic occurred during 2013–2017. B) Percentage of Bordetella pertussis isolates carrying ptxP3 allele in the 2 epidemic periods. C) Percentage of B. pertussis isolates carrying fim3A and fim3B allele in the 2 epidemic periods. D) Percentage of pertactin-expressing (Prn-positive) and pertactin-deficient (Prn-negative) B. pertussis isolates in the 2 epidemic periods. ACV, acellular vaccine; Prn, pertactin; WCV, whole-cell vaccine.
Figure 2
Figure 2
Phylogenomic relationship of 105 Bordetella pertussis epidemic isolates from Australia. The minimum-evolution tree was constructed using 705 SNPs. The isolates are labeled by name (L numbers), followed by states with color to indicate years of isolates. Shaded areas inside circle indicate ELs (EL1–EL5) and branches with isolates belonging to SP18 and those carrying fim3B and prn3 alleles. Prn-positive isolates and different mechanisms of Prn-negative isolates are marked by circles with different colors. Scale bar represents 3 SNPs. EL, epidemic lineage; NSW, New South Wales; Prn, pertactin; SNP, single-nucleotide polymorphism; SP, SNP profile; WA, Western Australia.

Similar articles

Cited by

References

    1. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014;20:626–33. 10.3201/eid2004.131478 - DOI - PMC - PubMed
    1. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis. 2012;205:1220–4. 10.1093/infdis/jis178 - DOI - PubMed
    1. Octavia S, Maharjan RP, Sintchenko V, Stevenson G, Reeves PR, Gilbert GL, et al. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol. 2011;28:707–15. 10.1093/molbev/msq245 - DOI - PubMed
    1. Safarchi A, Octavia S, Wu SZ, Kaur S, Sintchenko V, Gilbert GL, et al. Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. J Infect. 2016;72:468–77. 10.1016/j.jinf.2016.01.005 - DOI - PubMed
    1. Williamson P, Matthews R. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol Med Microbiol. 1996;13:169–78. - PubMed

Publication types

MeSH terms

Substances